General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statement of Changes in Convertible Preferred Stock and Stockholders' Deficit

v3.21.2
Condensed Consolidated Statement of Changes in Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Total
Convertible preferred stock
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Note Receivable [Member]
Accumulated Deficit [Member]
Total [Member]
Beginning balance at Dec. 31, 2018 $ (30,325) $ 54,541   $ 1,379     $ (31,704) $ 24,216
Beginning balance, Shares at Dec. 31, 2018   95,819,538 37,010,424          
Issuance of Series D convertible preferred stock   $ 82,126           82,126
Issuance of Series D convertible preferred stock, Shares   17,305,052            
Exercise of common stock options 390     560   $ (170)   390
Exercise of common stock options, Shares     2,249,293          
Repurchase of Series Seed convertible preferred stock (785) $ (20)   (785)       (805)
Repurchase of Series Seed convertible preferred stock, Shares   (315,637)            
Repurchase of common stock (624)       $ (624)     (624)
Repurchase of common stock, Shares     244,691   244,691      
Stock-based compensation 858     858       858
Exercise of Series D warrants   $ 150           150
Exercise of Series D warrants, Shares   31,564            
Net loss and comprehensive loss (29,875)           (29,875) (29,875)
Ending Balance at Dec. 31, 2019 (60,361) $ 136,797   2,012 $ (624) (170) (61,579) 76,436
Ending Balance, Shares at Dec. 31, 2019   112,840,517 39,259,717   244,691      
Exercise of common stock options 600     430   170   600
Exercise of common stock options, Shares     850,079          
Stock-based compensation 504     504       504
Exercise of Series D warrants   $ 50           50
Exercise of Series D warrants, Shares   10,520            
Net loss and comprehensive loss (5,245)           (5,245) (5,245)
Ending Balance at Mar. 31, 2020 (64,502) $ 136,847   2,946 $ (624)   (66,824) 72,345
Ending Balance, Shares at Mar. 31, 2020   112,851,037 40,109,796   244,691      
Beginning balance at Dec. 31, 2019 (60,361) $ 136,797   2,012 $ (624) (170) (61,579) 76,436
Beginning balance, Shares at Dec. 31, 2019   112,840,517 39,259,717   244,691      
Net loss and comprehensive loss (10,934)              
Ending Balance at Jun. 30, 2020 (69,633) $ 137,147   3,504 $ (624)   (72,513) 67,514
Ending Balance, Shares at Jun. 30, 2020   112,914,163 40,464,583   244,691      
Beginning balance at Dec. 31, 2019 (60,361) $ 136,797   2,012 $ (624) (170) (61,579) 76,436
Beginning balance, Shares at Dec. 31, 2019   112,840,517 39,259,717   244,691      
Exercise of common stock options 1,131     961   $ 170   1,131
Exercise of common stock options, Shares     2,231,540          
Repurchase of common stock (826)       $ (826)     (826)
Repurchase of common stock, Shares     263,031   263,031      
Stock-based compensation 2,569     2,569       2,569
Exercise of Series D warrants   $ 700           700
Exercise of Series D warrants, Shares   147,293            
Net loss and comprehensive loss (17,985)           (17,985) (17,985)
Ending Balance at Dec. 31, 2020 (75,472) $ 137,497   5,542 $ (1,450)   (79,564) 62,025
Ending Balance, Shares at Dec. 31, 2020   112,987,810 41,491,257   507,722      
Beginning balance at Mar. 31, 2020 (64,502) $ 136,847   2,946 $ (624)   (66,824) 72,345
Beginning balance, Shares at Mar. 31, 2020   112,851,037 40,109,796   244,691      
Stock-based compensation 503     503       503
Exercise of common stock warrants 55     55       55
Exercise of common stock warrants, Shares     354,787          
Exercise of Series D warrants   $ 300           300
Exercise of Series D warrants, Shares   63,126            
Net loss and comprehensive loss (5,689)           (5,689) (5,689)
Ending Balance at Jun. 30, 2020 (69,633) $ 137,147   3,504 $ (624)   (72,513) 67,514
Ending Balance, Shares at Jun. 30, 2020   112,914,163 40,464,583   244,691      
Beginning balance at Dec. 31, 2020 (75,472) $ 137,497   5,542 $ (1,450)   (79,564) 62,025
Beginning balance, Shares at Dec. 31, 2020   112,987,810 41,491,257   507,722      
Exercise of common stock options 356     356       356
Exercise of common stock options, Shares     749,980          
Stock-based compensation 1,194     1,194       1,194
Exercise of Series D warrants   $ 100           100
Exercise of Series D warrants, Shares   21,042            
Net loss and comprehensive loss (10,019)           (10,019) (10,019)
Ending Balance at Mar. 31, 2021 (83,941) $ 137,597   7,092 $ (1,450)   (89,583) 53,656
Ending Balance, Shares at Mar. 31, 2021   113,008,852 42,241,237   507,722      
Beginning balance at Dec. 31, 2020 (75,472) $ 137,497   5,542 $ (1,450)   (79,564) 62,025
Beginning balance, Shares at Dec. 31, 2020   112,987,810 41,491,257   507,722      
Net loss and comprehensive loss (21,109)              
Ending Balance at Jun. 30, 2021 (91,399) $ 137,952   10,724 $ (1,450)   (100,673) 46,553
Ending Balance, Shares at Jun. 30, 2021   113,083,557 42,537,176   507,722      
Beginning balance at Mar. 31, 2021 (83,941) $ 137,597   7,092 $ (1,450)   (89,583) 53,656
Beginning balance, Shares at Mar. 31, 2021   113,008,852 42,241,237   507,722      
Exercise of common stock options 62     62       62
Exercise of common stock options, Shares     107,363          
Stock-based compensation 1,777     1,777       1,777
Exercise of Series D warrants   $ 355           355
Exercise of Series D warrants, Shares   74,705            
Exercise of common stock warrants, net of shares withheld for exercise 1,793     1,793       1,793
Exercise of common stock warrants, net of shares withheld for exercise, Shares     188,576          
Net loss and comprehensive loss (11,090)           (11,090) (11,090)
Ending Balance at Jun. 30, 2021 $ (91,399) $ 137,952   $ 10,724 $ (1,450)   $ (100,673) $ 46,553
Ending Balance, Shares at Jun. 30, 2021   113,083,557 42,537,176   507,722